Overview of Primary and Secondary Metabolites of Rugulopteryx okamurae Seaweed: Assessing Bioactivity, Scalability, and Molecular Mechanisms
Marine Drugs · 2025
DOI: 10.3390/md23090351 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Marine Drugs, 2025. Verfasst von Ana Minerva García-Cervantes und 2 weiteren Autor:innen. Beteiligte Einrichtung: Food Technology Division, ceiA3, CIAMBITAL, University of Almería, 04120 Almería, Spain. Hauptthemen laut MEDLINE: Phaeophyceae, Seaweed. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia grants (Lisbon, Portugal), LA/P/0059/2020.
Abstract (Originalsprache)
Rugulopteryx okamurae is an invasive brown alga that has colonised Mediterranean and northeastern Atlantic coastlines, posing significant ecological and economic challenges. Its biomass is rich in structurally diverse metabolites—including polysaccharides (alginate, fucoidan, laminaran), phlorotannins, diterpenoids, fatty acids, and peptides—many of which exhibit notable antioxidant, anti-inflammatory, antimicrobial, and anticancer activities. Comparative assessment of extraction yields, structural features, and bioactivity data highlights phlorotannins and diterpenoids as particularly promising, demonstrating low-micromolar potencies and favourable predicted interactions with key inflammatory and apoptotic targets. Algal polysaccharides exhibit various bioactivities but hold strong potential for scalable and sustainable industrial applications. Emerging compound classes such as fatty acids and peptides display niche bioactivities; however, their structural diversity and mechanisms of action remain insufficiently explored. Insights from in vitro and in silico studies suggest that phlorotannins may modulate NF-κB and MAPK signalling pathways, while diterpenoids are implicated in the induction of mitochondrial apoptosis. Despite these findings, inconsistent extraction methodologies and a lack of in vivo pharmacokinetic and efficacy data limit translational potential. To overcome these limitations, standardized extraction protocols, detailed structure–activity relationship (SAR) and pharmacokinetic studies, and robust in vivo models are urgently needed. Bioactivity-guided valorisation strategies, aligned with ecological management, could transform R. okamurae biomass into a sustainable source for functional foods, cosmetics, and pharmaceuticals applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Food Technology Division, ceiA3, CIAMBITAL, University of Almería, 04120 Almería, Spain.
- CIISA-Centro de Investigação Interdisciplinar em Sanidade Animal, Faculdade de Medicina Veterinária, Universidade de Lisboa, 1300-477 Lisboa, Portugal.
- Associate Laboratory for Animal and Veterinary Sciences (AL4AnimalS), 1300-477 Lisboa, Portugal.
ORCID-Profile: Ana Minerva García-Cervantes, José A M Prates, José Luis Guil-Guerrero
Förderung
- Fundação para a Ciência e a Tecnologia grants (Lisbon, Portugal)
- LA/P/0059/2020
Zitieren
APA
García-Cervantes, A. M., Prates, J. A. M., & Guil-Guerrero, J. L. (2025). Overview of Primary and Secondary Metabolites of Rugulopteryx okamurae Seaweed: Assessing Bioactivity, Scalability, and Molecular Mechanisms. Marine Drugs. https://doi.org/10.3390/md23090351
Vancouver
García-Cervantes AM, Prates JAM, Guil-Guerrero JL. Overview of Primary and Secondary Metabolites of Rugulopteryx okamurae Seaweed: Assessing Bioactivity, Scalability, and Molecular Mechanisms. Marine Drugs. 2025. doi:10.3390/md23090351
BibTeX
@article{GarcaCervantes2025,
author = {García-Cervantes, Ana Minerva and Prates, José A M and Guil-Guerrero, José Luis},
title = {Overview of Primary and Secondary Metabolites of Rugulopteryx okamurae Seaweed: Assessing Bioactivity, Scalability, and Molecular Mechanisms},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23090351}
}
EUVIMED